Header cover image

Chinese (SSE) Life Sciences Industry Analysis

UpdatedMar 25, 2024
DataAggregated Company Financials
Companies24
  • 7D-5.1%
  • 3M-25.3%
  • 1Y-40.5%
  • YTD-23.8%

Over the last 7 days, the Life Sciences industry has dropped 5.1%, driven by declines from every company within the industry. However, the industry is down 40% over the past year. Looking forward, earnings are forecast to grow by 30% annually.

Industry Valuation and Performance

Has the Chinese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 26 Mar 2024CN¥345.3bCN¥90.4bCN¥15.6b33.9x22.1x3.8x
Thu, 22 Feb 2024CN¥355.5bCN¥91.1bCN¥16.1b31.2x22.1x3.9x
Sat, 20 Jan 2024CN¥452.3bCN¥91.1bCN¥16.1b35.4x28.1x5x
Mon, 18 Dec 2023CN¥479.2bCN¥91.1bCN¥16.1b37.3x29.8x5.3x
Wed, 15 Nov 2023CN¥550.9bCN¥91.1bCN¥16.1b40.1x34.3x6x
Fri, 13 Oct 2023CN¥544.2bCN¥92.0bCN¥18.3b36.4x29.7x5.9x
Sun, 10 Sep 2023CN¥470.0bCN¥91.9bCN¥18.3b32.3x25.7x5.1x
Tue, 08 Aug 2023CN¥481.8bCN¥91.8bCN¥18.5b34.8x26.1x5.2x
Thu, 06 Jul 2023CN¥460.3bCN¥91.3bCN¥18.5b34.8x24.9x5x
Sat, 03 Jun 2023CN¥500.0bCN¥91.3bCN¥18.5b38.6x27.1x5.5x
Mon, 01 May 2023CN¥514.4bCN¥92.3bCN¥18.9b43.1x27.2x5.6x
Wed, 29 Mar 2023CN¥599.7bCN¥90.2bCN¥19.9b49.2x30.2x6.6x
Fri, 24 Feb 2023CN¥624.7bCN¥86.6bCN¥20.8b53.7x30x7.2x
Sun, 22 Jan 2023CN¥713.5bCN¥86.6bCN¥20.8b60.6x34.3x8.2x
Tue, 20 Dec 2022CN¥566.3bCN¥86.6bCN¥20.8b47.1x27.2x6.5x
Thu, 17 Nov 2022CN¥655.6bCN¥86.5bCN¥20.8b56.5x31.5x7.6x
Sat, 15 Oct 2022CN¥585.1bCN¥78.2bCN¥16.9b48.8x34.6x7.5x
Mon, 12 Sep 2022CN¥614.4bCN¥77.8bCN¥17.0b49.6x36.1x7.9x
Wed, 10 Aug 2022CN¥638.6bCN¥73.3bCN¥17.1b67.8x37.4x8.7x
Fri, 08 Jul 2022CN¥740.3bCN¥69.0bCN¥15.2b74.4x48.7x10.7x
Sun, 05 Jun 2022CN¥577.0bCN¥69.0bCN¥15.2b55.6x38x8.4x
Tue, 03 May 2022CN¥619.7bCN¥68.4bCN¥15.1b59x41x9.1x
Thu, 31 Mar 2022CN¥684.3bCN¥62.7bCN¥15.0b65.8x45.6x10.9x
Sat, 26 Feb 2022CN¥606.5bCN¥59.2bCN¥13.3b64.6x45.7x10.2x
Mon, 24 Jan 2022CN¥661.1bCN¥57.5bCN¥12.3b70.2x53.7x11.5x
Wed, 22 Dec 2021CN¥727.9bCN¥56.9bCN¥12.1b81.4x59.9x12.8x
Fri, 19 Nov 2021CN¥839.8bCN¥56.9bCN¥12.1b92.6x69.1x14.8x
Sun, 17 Oct 2021CN¥915.4bCN¥53.4bCN¥11.5b109.8x79.5x17.2x
Tue, 14 Sep 2021CN¥941.3bCN¥55.1bCN¥12.7b94.3x73.9x17.1x
Thu, 12 Aug 2021CN¥902.9bCN¥53.4bCN¥11.5b104.4x78.4x16.9x
Mon, 07 Jun 2021CN¥856.8bCN¥46.5bCN¥10.6b93.7x81.1x18.4x
Price to Earnings Ratio

66.3x


Total Market Cap: CN¥691.7bTotal Earnings: CN¥10.4bTotal Revenue: CN¥44.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Life Sciences Industry Price to Earnings3Y Average 43.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Chinese Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 22.1x which is lower than its 3-year average PE of 43.5x.
  • The 3-year average PS ratio of 9.5x is higher than the industry's current PS ratio of 3.8x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 14% per year over the last three years.
  • Revenues for these companies have grown 26% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare industry?

CN Market-0.029%
Healthcare-2.16%
Life Sciences-5.10%
Clinical Research and Equipment-5.10%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.